Rheumatology Flashcards
what is systemic sclerosis
Systemic sclerosis is a condition of unknown aetiology characterised by hardened, sclerotic skin and other connective tissues. It is four times more common in females.
Limited cutaneous systemic sclerosis
Raynaud’s may be first sign
scleroderma affects face and distal limbs predominately
associated with anti-centromere antibodies
a subtype of limited systemic sclerosis is CREST syndrome: Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, Telangiectasia
What is CREST
Calcinosis Raynaud's phenomenon oEsophageal dysmotility Sclerodactyly Telangiectasia
Diffuse cutaneous systemic sclerosis
scleroderma affects trunk and proximal limbs predominately
associated with scl-70 antibodies
the most common cause of death is now respiratory involvement, which is seen in around 80%: interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH)
other complications include renal disease and hypertension
poor prognosis
Scleroderma (without internal organ involvement)
tightening and fibrosis of skin
may be manifest as plaques (morphoea) or linear
Systemic sclerosis antibodies
ANA positive in 90%
RF positive in 30%
anti-scl-70 antibodies associated with diffuse cutaneous systemic sclerosis
anti-centromere antibodies associated with limited cutaneous systemic sclerosis
What is pseudogout?
Pseudogout is a form of microcrystal synovitis caused by the deposition of calcium pyrophosphate dihydrate crystals in the synovium. For this reason, it is now more correctly termed acute calcium pyrophosphate crystal deposition disease.
Risk factors for pseudogout
Pseudogout is strongly associated with increasing age. Patients who develop pseudogout at a younger age (e.g. < 60 years) usually have some underlying risk factor, such as: haemochromatosis hyperparathyroidism low magnesium, low phosphate acromegaly, Wilson's disease
Features of pseudogout
knee, wrist and shoulders most commonly affected
joint aspiration: weakly-positively birefringent rhomboid-shaped crystals
x-ray: chondrocalcinosis
in the knee this can be seen as linear calcifications of the meniscus and articular cartilage
Management of pseudogout
aspiration of joint fluid, to exclude septic arthritis
NSAIDs or intra-articular, intra-muscular or oral steroids as for gout
Features of drug induced lupus
arthralgia
myalgia
skin (e.g. malar rash) and pulmonary involvement (e.g. pleurisy) are common
ANA positive in 100%, dsDNA negative
anti-histone antibodies are found in 80-90%
anti-Ro, anti-Smith positive in around 5%
Most common causes of drug induced lupus
procainamide
hydralazine
Least common causes of drug induced lupus
isoniazid
minocycline
phenytoin
What is polyarteritis nodosa
Polyarteritis nodosa (PAN) is a vasculitis affecting medium-sized arteries with necrotizing inflammation leading to aneurysm formation. PAN is more common in middle-aged men and is associated with hepatitis B infection.
Features of polyarteritis nodosa
fever, malaise, arthralgia
weight loss
hypertension
mononeuritis multiplex, sensorimotor polyneuropathy
testicular pain
livedo reticularis
haematuria, renal failure
perinuclear-antineutrophil cytoplasmic antibodies (ANCA) are found in around 20% of patients with ‘classic’ PAN
hepatitis B serology positive in 30% of patients
SLE antibodies
99% are ANA positive
this high sensitivity makes it a useful rule out test, but it has low specificity
20% are rheumatoid factor positive
anti-dsDNA: highly specific (> 99%), but less sensitive (70%)
anti-Smith: highly specific (> 99%), sensitivity (30%)
also: anti-U1 RNP, SS-A (anti-Ro) and SS-B (anti-La)
SLE monitoring investigations
Inflammatory markers
ESR is generally used
during active disease the CRP may be normal - a raised CRP may indicate underlying infection
complement levels (C3, C4) are low during active disease (formation of complexes leads to consumption of complement)
anti-dsDNA titres can be used for disease monitoring (but note not present in all patients)
Mechanism of action of methotrexate
Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, an enzyme essential for the synthesis of purines and pyrimidines. It is considered an ‘important’ drug as whilst it can be very effective in controlling disease the side-effects may be potentially life-threatening - careful prescribing and close monitoring is essential.
Indications for Methotrexate
nflammatory arthritis, especially rheumatoid arthritis
psoriasis
some chemotherapy acute lymphoblastic leukaemia
Adverse effects of methotrexate
mucositis myelosuppression pneumonitis pulmonary fibrosis liver fibrosis hepatotoxicity
Pregnancy and methotrexate
women should avoid pregnancy for at least 6 months after treatment has stopped
the BNF also advises that men using methotrexate need to use effective contraception for at least 6 months after treatment
Prescribing methotrexate
methotrexate is a drug with a high potential for patient harm. It is therefore important that you are familiar with guidelines relating to its use
methotrexate is taken weekly, rather than daily
FBC, U&E and LFTs need to be regularly monitored. The Committee on Safety of Medicines recommend ‘FBC and renal and LFTs before starting treatment and repeated weekly until therapy stabilised, thereafter patients should be monitored every 2-3 months’
folic acid 5mg once weekly should be co-prescribed, taken more than 24 hours after methotrexate dose
the starting dose of methotrexate is 7.5 mg weekly (source: BNF)
only one strength of methotrexate tablet should be prescribed (usually 2.5 mg)
Methotrexate interactions
avoid prescribing trimethoprim or co-trimoxazole concurrently - increases risk of marrow aplasia
high-dose aspirin increases the risk of methotrexate toxicity secondary to reduced excretion
What is Behcet’s syndrome
Behcet’s syndrome is a complex multisystem disorder associated with presumed autoimmune-mediated inflammation of the arteries and veins. The precise aetiology has yet to be elucidated however. The classic triad of symptoms are oral ulcers, genital ulcers and anterior uveitis
Epidemiology of Behcet’s syndrome
more common in the eastern Mediterranean (e.g. Turkey)
more common in men (complicated gender distribution which varies according to country. Overall, Behcet’s is considered to be more common and more severe in men)
tends to affect young adults (e.g. 20 - 40 years old)
associated with HLA B51- more specifically HLA B51, a split antigen of HLA B5
around 30% of patients have a positive family history
Features of Behcet’s syndrome
classically: 1) oral ulcers 2) genital ulcers 3) anterior uveitis
thrombophlebitis and deep vein thrombosis
arthritis
neurological involvement (e.g. aseptic meningitis)
GI: abdo pain, diarrhoea, colitis
erythema nodosum
Diagnosis of Behcet’s syndrome
no definitive test
diagnosis based on clinical findings
positive pathergy test is suggestive (puncture site following needle prick becomes inflamed with small pustule forming)
Causes of Osteomalacia
vitamin D deficiency malabsorption lack of sunlight diet chronic kidney disease drug induced e.g. anticonvulsants inherited: hypophosphatemic rickets (previously called vitamin D-resistant rickets) liver disease: e.g. cirrhosis
Features of Osteomalacia
bone pain
bone/muscle tenderness
fractures: especially femoral neck
proximal myopathy: may lead to a waddling gait
Investigations of osteomalacia
bloods
low vitamin D levels
low calcium, phosphate (in around 30%)
raised alkaline phosphatase (in 95-100% of patients)
x-ray
translucent bands (Looser’s zones or pseudofractures
Treatment of osteomalacia
vitamin D supplmentation
a loading dose is often needed initially
calcium supplementation if dietary calcium is inadequate
Bone profile
osteoporosis
Normal Ca
Normal phosphate
Normal ALP
Normal PTH
Bone Profile
Osteomalacia
Decreased Ca
Decreased phosphate
Increased ALP
Increased PTH
Bone Profile
Primary hyperparathyroidism (→ osteitis fibrosa cystica)
IncreasedCa
Decreased phosphate
Increased ALP
Increased PTH
Bone Profile
Chronic kidney disease (→ secondary hyperparathyroidism)
Decreased Ca
Increased phosphate
Increased ALP
Increased PTH
Bone profile
Paget’s disease
Normal Ca
Normal phosphate
Increased ALP
Normal PTH
Bone Profile
Osteopetrosis
Normal Ca
Normal phosphate
Normal ALP
Normal PTH
What is Sjogren’s syndrome
autoimmune disorder affecting exocrine glands resulting in dry mucosal surfaces. It may be primary (PSS) or secondary to rheumatoid arthritis or other connective tissue disorders, where it usually develops around 10 years after the initial onset. Sjogren’s syndrome is much more common in females (ratio 9:1). There is a marked increased risk of lymphoid malignancy (40-60 fold).
Features of Sjogren’s syndrome
dry eyes: keratoconjunctivitis sicca dry mouth vaginal dryness arthralgia Raynaud's, myalgia sensory polyneuropathy recurrent episodes of parotitis renal tubular acidosis (usually subclinical)
investigations for Sjogren’s syndrome
rheumatoid factor (RF) positive in nearly 50% of patients
ANA positive in 70%
anti-Ro (SSA) antibodies in 70% of patients with PSS
anti-La (SSB) antibodies in 30% of patients with PSS
Schirmer’s test: filter paper near conjunctival sac to measure tear formation
histology: focal lymphocytic infiltration
also: hypergammaglobulinaemia, low C4
Management of Sjogren’s syndrome
artificial saliva and tears
pilocarpine may stimulate saliva production
What is polymyositis
inflammatory disorder causing symmetrical, proximal muscle weakness
thought to be a T-cell mediated cytotoxic process directed against muscle fibres
may be idiopathic or associated with connective tissue disorders
associated with malignancy
dermatomyositis is a variant of the disease where skin manifestations are prominent, for example a purple (heliotrope) rash on the cheeks and eyelids
typically affects middle-aged, female:male 3:1
Features of polymyositis
proximal muscle weakness +/- tenderness Raynaud's respiratory muscle weakness interstitial lung disease: e.g. fibrosing alveolitis or organising pneumonia dysphagia, dysphonia
Investigations for polymyositis
elevated creatine kinase
other muscle enzymes (lactate dehydrogenase (LDH), aldolase, AST and ALT) are also elevated in 85-95% of patients
EMG
muscle biopsy
anti-synthetase antibodies
anti-Jo-1 antibodies are seen in pattern of disease associated with lung involvement, Raynaud’s and fever
Investigations of dermatomysositis
elevated creatine kinase
EMG
muscle biopsy
ANA positive in 60%
anti-Mi-2 antibodies are highly specific for dermatomyositis, but are only seen in around 25% of patients
anti-Jo-1 antibodies are not commonly seen in dermatomyositis - they are more common in polymyositis where they are seen in a pattern of disease associated with lung involvement, Raynaud’s and fever
Management of dermatomyositis
prednisolone
Methotrexate side effects
Myelosuppression
Liver cirrhosis
Pneumonitis
Sulfasalazine side effects
Rashes
Oligospermia
Heinz body anaemia
Interstitial lung disease
Leflunomide side effects
Liver impairment
Interstitial lung disease
Hypertension
Hydroxychloroquine side effects
Retinopathy
Corneal deposits
Prednisolone side effects
Cushingoid features Osteoporosis Impaired glucose tolerance Hypertension Cataracts
Gold side effects
Proteinuria
Penicillamine side effects
Proteinuria
Exacerbation of myasthenia gravis
Etanercept side effects
Demyelination
Reactivation of tuberculosis
Infliximab side effects
Reactivation of tuberculosis
Adalimumab side effects
Reactivation of TB